Shares of LexaGene Holdings Inc. (CVE:LXG – Get Free Report) fell 19.2% during trading on Wednesday . The stock traded as low as C$0.10 and last traded at C$0.11. 2,135,375 shares were traded during trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Trading Down 19.2 %
The company has a debt-to-equity ratio of 138.01, a current ratio of 1.39 and a quick ratio of 1.13. The firm’s 50 day moving average is C$0.11 and its 200 day moving average is C$0.11. The company has a market capitalization of C$14.77 million, a PE ratio of -1.31 and a beta of 2.26.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Recommended Stories
- Five stocks we like better than LexaGene
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
- How to Use the MarketBeat Excel Dividend Calculator
- 4 Quirky ETFs With Big Potential for Impressive Gains
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
